Product Images Valacyclovir
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Valacyclovir NDC 61919-066 by Direct Rx, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image description - Label
This is a product description of Valacyclovir, a medication used to treat herpes virus infections. It comes as a 500mg tablet and is sold in a bottle of 60 tablets. There are details about the drug including the active ingredient, Valacyclovir Hydrochloride, which is USP equivalent to Valacyclovir 500mg. The package has a lot expiration date, although the text is not clear. The drug is meant for prescription only and customers are advised to keep it out of reach of children. Specific dosage instructions are not provided, so customers should consult with their physicians.*
image description - Molecule
Valacyclovir hydrochloride is a medication available in the form of white to off-white powder. Its molecular formula is Cy3HoNeOz+HCL, and it has a maximum solubility of 174 mg/mL in water at 25°C. The pKss for the medication are 1.90, 7.47, and 9.43.*
image description - Table2
image description - Table3
This text appears to be a chart comparing the effectiveness of Valacyclovir (a medication commonly used to treat herpes) versus a placebo. It includes information on dosages, frequency of administration, and various laboratory abnormalities observed in test subjects. No other information or context is provided.*
image description - Table4
This text appears to be a table presenting the results of a study regarding the suppression of genital herpes with the use of Valacyclovir and Placebo. The table displays the number of participants in each group, dosages given, and percentages of occurrences. Without further context, it is difficult to provide more information.*
image description - Table5
This appears to be a tabular format of data with variable dosages administered as single-dose and multiple-dose administration. The data seems to contain measurements of Crsx, AUC, and Cansx at different time points and treatment arms for each dosage. However, it is difficult to interpret the data without additional information on the subject matter.*
image description - Table6
image description - Table7
image description - Table8
This text presents the outcome of a study comparing the efficacy of Valacyclovir Hydrochloride versus placebo in preventing recurrences of a certain condition. The study involved 99 participants who received 500 mg of Valacyclovir Hydrochloride twice daily and 194 participants who received a placebo. The results showed that the Valacyclovir Hydrochloride group had a recurrence-free rate of 65% compared to the placebo group that had only 26%. Recurrences occurred in 17% of the Valacyclovir Hydrochloride group and 57% of the placebo group, while 18% of the Valacyclovir Hydrochloride group and 17% of the placebo group had unknown outcomes.*
image description - Table9
The text provides a table showing the percentage of susceptible partners who acquired the HSV-2 virus after being administered Valacyclovir® or Placebo. The table shows the results for three different endpoints, namely Symptomatic HSV-2 acquisition, HSV-2 seroconversion, and Overall HSV-2 acquisition, with corresponding percentages for both Valacyclovir® and Placebo.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.